These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21974814)

  • 21. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery.
    Turanlahti M; Boldt T; Palkama T; Antila S; Lehtonen L; Pesonen E
    Pediatr Crit Care Med; 2004 Sep; 5(5):457-62. PubMed ID: 15329162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful use of levosimendan as a primary inotrope in pediatric cardiac surgery: An observational study in 110 patients.
    Joshi RK; Aggarwal N; Aggarwal M; Pandey R; Dinand V; Joshi R
    Ann Pediatr Cardiol; 2016; 9(1):9-15. PubMed ID: 27011685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Levosimendan in Patients with Decreased Left Ventricular Function Undergoing Cardiac Surgery.
    Bozhinovska M; Taleska G; Fabian A; Šoštarič M
    Open Access Maced J Med Sci; 2016 Sep; 4(3):510-516. PubMed ID: 27703584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
    Mehta RH; Van Diepen S; Meza J; Bokesch P; Leimberger JD; Tourt-Uhlig S; Swartz M; Parrotta J; Jankowich R; Hay D; Harrison RW; Fremes S; Goodman SG; Luber J; Toller W; Heringlake M; Anstrom KJ; Levy JH; Harrington RA; Alexander JH;
    Am Heart J; 2016 Dec; 182():62-71. PubMed ID: 27914501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
    Burkhardt BE; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009515. PubMed ID: 25806562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic effects of levosimendan following cardiac surgery].
    Alvarez J; Taboada M; Rodríguez J; Caruezo V; Bouzada M; Campaña O; Bascuas B; Pérez-Paz J; Ginesta V
    Rev Esp Anestesiol Reanim; 2005; 52(7):389-94. PubMed ID: 16200918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M; Lehtonen L
    Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Levosimendan Compared to Conventional Inotropic Agents on Hemodynamics and Outcome in Patient with Poor LV Function Undergoing Cardiac Surgery.
    Khaled M; Almogy AN; Shehata M; Ragab F; Zeineldin K
    Open Access Maced J Med Sci; 2019 Oct; 7(19):3205-3210. PubMed ID: 31949517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
    Mebazaa A; Nieminen MS; Packer M; Cohen-Solal A; Kleber FX; Pocock SJ; Thakkar R; Padley RJ; Põder P; Kivikko M;
    JAMA; 2007 May; 297(17):1883-91. PubMed ID: 17473298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y
    Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
    Tek M; Cavuşoğlu Y; Demirüstü C; Birdane A; Ünalır A; Görenek B; Göktekin Ö; Ata N
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):334-40. PubMed ID: 21200103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
    Zangrillo A; Alvaro G; Pisano A; Guarracino F; Lobreglio R; Bradic N; Lembo R; Gianni S; Calabrò MG; Likhvantsev V; Grigoryev E; Buscaglia G; Pala G; Auci E; Amantea B; Monaco F; De Vuono G; Corcione A; Galdieri N; Cariello C; Bove T; Fominskiy E; Auriemma S; Baiocchi M; Bianchi A; Frontini M; Paternoster G; Sangalli F; Wang CY; Zucchetti MC; Biondi-Zoccai G; Gemma M; Lipinski MJ; Lomivorotov VV; Landoni G
    Am Heart J; 2016 Jul; 177():66-73. PubMed ID: 27297851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experiences of levosimendan as an inotropic agent in conjunction with passive containment surgery.
    Bredin F; Franco-Cereceda A
    Scand Cardiovasc J; 2007 Jun; 41(3):197-200. PubMed ID: 17487771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.
    Slawsky MT; Colucci WS; Gottlieb SS; Greenberg BH; Haeusslein E; Hare J; Hutchins S; Leier CV; LeJemtel TH; Loh E; Nicklas J; Ogilby D; Singh BN; Smith W
    Circulation; 2000 Oct; 102(18):2222-7. PubMed ID: 11056096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic effects of levosimendan in advanced but stable chronic heart failure.
    Najjar E; Stålhberg M; Hage C; Ottenblad E; Manouras A; Haugen Löfman I; Lund LH
    ESC Heart Fail; 2018 Jun; 5(3):302-308. PubMed ID: 29469177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.
    Lahtinen P; Pitkänen O; Pölönen P; Turpeinen A; Kiviniemi V; Uusaro A
    Crit Care Med; 2011 Oct; 39(10):2263-70. PubMed ID: 21666445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic support of a 15-year-old waiting for a heart transplant: Is there a role for levosimendan in pediatric heart failure?
    Goyer I; Brossier D; Toledano B
    Arch Pediatr; 2018 Feb; 25(2):132-135. PubMed ID: 29395891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Levosimendan on Renal Outcome in Cardiac Surgery Patients With Chronic Kidney Disease and Perioperative Cardiovascular Dysfunction: A Substudy of a Multicenter Randomized Trial.
    Zangrillo A; Alvaro G; Belletti A; Pisano A; Brazzi L; Calabrò MG; Guarracino F; Bove T; Grigoryev EV; Monaco F; Boboshko VA; Likhvantsev VV; Scandroglio AM; Paternoster G; Lembo R; Frassoni S; Comis M; Pasyuga VV; Navalesi P; Lomivorotov VV;
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2152-2159. PubMed ID: 29580796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study).
    Caruba T; Hourton D; Sabatier B; Rousseau D; Tibi A; Hoffart-Jourdain C; Souag A; Freitas N; Yjjou M; Almeida C; Gomes N; Aucouturier P; Djadi-Prat J; Menasché P; Chatellier G; Cholley B
    J Cardiothorac Surg; 2016 Aug; 11(1):127. PubMed ID: 27496105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
    Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.